Brensocatib has demonstrated efficacy in reducing neutrophil serine protease activity and symptom burden in non-cystic fibrosis bronchiectasis. GLP-1 inhibitors show potential in managing obstructive ...

— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J., Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (INSM ...

Bronchiectasis is a long-term health condition in which airways are constantly irritated or inflamed, leading to permanent airway damage and a buildup of mucus. This often causes a chronic cough and ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Researchers analyzed a US national database to compare outcomes of hospitalizations for bronchiectasis exacerbations with those for COPD and asthma exacerbations among adults hospitalized between 2017 ...